Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lai H et al. | 2004 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 10–500 µT |
Li SH et al. | 2001 | DNA/RNA, bacterium, plasmid pUC18, <i>Escherichia coli</i>/XL1-Blue transformed with plasmid pUC18 | magnetic field, 50/60 Hz | 1.2 mT |
Li Y et al. | 2014 | intact cell/cell culture, culture medium, K562 and HEL 92.1.7 cells (human erythroleukemic cell lines), MCF-7 cells (human breast cancer cell line), NCI-H460 cells (human lung cancer cell line), Colo 320 DM cells (human colon carcinoma cell line) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 4 nT–74 µT |
Livingston GK et al. | 1991 | intact cell/cell culture, human peripheral blood lymphocytes and Chinese hamster ovary (CHO) cells | magnetic field, 50/60 Hz, electric current application | 0.22 mT |
Lloyd D et al. | 2004 | intact cell/cell culture, human lymphocytes | magnetic field, low frequency, 50/60 Hz, co-exposure | 230–700 µT |
Lopucki M et al. | 2005 | placenta sample (cotyledon) | magnetic field, 50/60 Hz | 2–5 mT |
Luceri C et al. | 2005 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>/strain DBY747) | magnetic field, low frequency, 50/60 Hz | 0.1–100 µT |
Luo Q et al. | 2006 | ICR mouse embryo cultures | 50/60 Hz, magnetic field, low frequency, co-exposure | 0.3–0.5 mT |
Luukkonen J et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 100 µT |
Luukkonen J et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.